Phase II Study of Neoadjuvant Letrozole for Postmenopausal Women With Estrogen Receptor Positive Ductal Carcinoma In SITU (DCIS).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 27 Mar 2018 Biomarkers information updated
- 18 Aug 2012 New source identified and integrated (M.D. Anderson Cancer Center: CALGB40903).
- 10 Jun 2012 New source identified and integrated (Mayo Clinic, 12-002183).